Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
Home
 
       Home    Substance
     
1 result for Name/Synonym equals BOSUTINIB 
PropertyValue
Drug Name: Bosutinib [USAN:INN] View Structure
Description: A 4-anilino-3-quinolinecarbonitrile dual inhibitor of Src and Abl kinases.

NCI: A drug used to treat chronic myelogenous leukemia (CML). It is used in patients who cannot be treated with or have not gotten better with other treatment. It is also being studied in the treatment of other types of cancer. Bosutinib blocks the action of BCR-ABL and other proteins, which may help keep cancer cells from growing and may kill cancer cells. It is a type of tyrosine kinase inhibitor. Also called Bosulif. 
Category:



 
 
Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Aug 2016
USA.gov